ID   ACK1_HUMAN              Reviewed;        1047 AA.
AC   Q07912-3;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   12-OCT-2022, entry version 224.
DE   RecName: Full=Isoform 3 of Activated CDC42 kinase 1;
DE            Short=ACK-1;
DE            EC=2.7.10.2 {ECO:0000269|PubMed:10652228, ECO:0000269|PubMed:16257963, ECO:0000269|PubMed:16472662, ECO:0000269|PubMed:18993068, ECO:0000269|PubMed:20333297};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:16257963, ECO:0000269|PubMed:18993068};
DE   AltName: Full=Tyrosine kinase non-receptor protein 2;
GN   Name=TNK2; Synonyms=ACK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH CDC42.
RC   TISSUE=Hippocampus;
RX   PubMed=8497321; DOI=10.1038/363364a0;
RA   Manser E., Leung T., Salihuddin H., Tan L., Lim L.;
RT   "A non-receptor tyrosine kinase that inhibits the GTPase activity of
RT   p21cdc42.";
RL   Nature 363:364-367(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT LEU-725.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH CSPG4.
RX   PubMed=10587647; DOI=10.1038/70302;
RA   Eisenmann K.M., McCarthy J.B., Simpson M.A., Keely P.J., Guan J.-L.,
RA   Tachibana K., Lim L., Manser E., Furcht L.T., Iida J.;
RT   "Melanoma chondroitin sulphate proteoglycan regulates cell spreading
RT   through Cdc42, Ack-1 and p130cas.";
RL   Nat. Cell Biol. 1:507-513(1999).
RN   [6]
RP   FUNCTION AS MCF2 KINASE, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=10652228; DOI=10.1006/bbrc.2000.2106;
RA   Kato J., Kaziro Y., Satoh T.;
RT   "Activation of the guanine nucleotide exchange factor Dbl following ACK1-
RT   dependent tyrosine phosphorylation.";
RL   Biochem. Biophys. Res. Commun. 268:141-147(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=11278436; DOI=10.1074/jbc.m008795200;
RA   Teo M., Tan L., Lim L., Manser E.;
RT   "The tyrosine kinase ACK1 associates with clathrin-coated vesicles through
RT   a binding motif shared by arrestin and other adaptors.";
RL   J. Biol. Chem. 276:18392-18398(2001).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14733946; DOI=10.1016/j.bbrc.2003.12.137;
RA   Ahmed I., Calle Y., Sayed M.A., Kamal J.M., Rengaswamy P., Manser E.,
RA   Meiners S., Nur-E-Kamal A.;
RT   "Cdc42-dependent nuclear translocation of non-receptor tyrosine kinase,
RT   ACK.";
RL   Biochem. Biophys. Res. Commun. 314:571-579(2004).
RN   [9]
RP   AUTOPHOSPHORYLATION, INTERACTION WITH HSP90AB1; MTERK AND WWOX, AND
RP   MUTAGENESIS OF LYS-158 AND LEU-487.
RX   PubMed=16288044; DOI=10.1158/0008-5472.can-05-1127;
RA   Mahajan N.P., Whang Y.E., Mohler J.L., Earp H.S.;
RT   "Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of
RT   Ack1 in polyubiquitination of tumor suppressor Wwox.";
RL   Cancer Res. 65:10514-10523(2005).
RN   [10]
RP   INTERACTION WITH SNX9, AND SUBCELLULAR LOCATION.
RX   PubMed=16137687; DOI=10.1016/j.febslet.2005.07.093;
RA   Yeow-Fong L., Lim L., Manser E.;
RT   "SNX9 as an adaptor for linking synaptojanin-1 to the Cdc42 effector
RT   ACK1.";
RL   FEBS Lett. 579:5040-5048(2005).
RN   [11]
RP   FUNCTION AS WAS KINASE, INTERACTION WITH WASL, CATALYTIC ACTIVITY, AND
RP   COFACTOR.
RX   PubMed=16257963; DOI=10.1074/jbc.m506996200;
RA   Yokoyama N., Lougheed J., Miller W.T.;
RT   "Phosphorylation of WASP by the Cdc42-associated kinase ACK1: dual
RT   hydroxyamino acid specificity in a tyrosine kinase.";
RL   J. Biol. Chem. 280:42219-42226(2005).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16247015; DOI=10.1073/pnas.0508014102;
RA   van der Horst E.H., Degenhardt Y.Y., Strelow A., Slavin A., Chinn L.,
RA   Orf J., Rong M., Li S., See L.-H., Nguyen K.Q.C., Hoey T., Wesche H.,
RA   Powers S.;
RT   "Metastatic properties and genomic amplification of the tyrosine kinase
RT   gene ACK1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:15901-15906(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   FUNCTION IN CELL MIGRATION, AND INTERACTION WITH BCAR1; CDC42 AND CRK.
RX   PubMed=17038317; DOI=10.1074/jbc.m604342200;
RA   Modzelewska K., Newman L.P., Desai R., Keely P.J.;
RT   "Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas.";
RL   J. Biol. Chem. 281:37527-37535(2006).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PHOSPHORYLATION AT TYR-284.
RX   PubMed=16472662; DOI=10.1016/s0076-6879(06)06018-6;
RA   Yokoyama N., Miller W.T.;
RT   "Purification and enzyme activity of ACK1.";
RL   Methods Enzymol. 406:250-260(2006).
RN   [17]
RP   INTERACTION WITH AR.
RX   PubMed=17494760; DOI=10.1073/pnas.0700420104;
RA   Mahajan N.P., Liu Y., Majumder S., Warren M.R., Parker C.E., Mohler J.L.,
RA   Earp H.S., Whang Y.E.;
RT   "Activated Cdc42-associated kinase Ack1 promotes prostate cancer
RT   progression via androgen receptor tyrosine phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:8438-8443(2007).
RN   [18]
RP   INTERACTION WITH NPHP1.
RX   PubMed=18477472; DOI=10.1016/j.bbrc.2008.05.016;
RA   Eley L., Moochhala S.H., Simms R., Hildebrandt F., Sayer J.A.;
RT   "Nephrocystin-1 interacts directly with Ack1 and is expressed in human
RT   collecting duct.";
RL   Biochem. Biophys. Res. Commun. 371:877-882(2008).
RN   [19]
RP   FUNCTION.
RX   PubMed=18435854; DOI=10.1186/bcr2087;
RA   Howlin J., Rosenkvist J., Andersson T.;
RT   "TNK2 preserves epidermal growth factor receptor expression on the cell
RT   surface and enhances migration and invasion of human breast cancer cells.";
RL   Breast Cancer Res. 10:R36-R36(2008).
RN   [20]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18262180; DOI=10.1016/j.yexcr.2007.12.017;
RA   Groevdal L.M., Johannessen L.E., Roedland M.S., Madshus I.H., Stang E.;
RT   "Dysregulation of Ack1 inhibits down-regulation of the EGF receptor.";
RL   Exp. Cell Res. 314:1292-1300(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-881, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   INTERACTION WITH NEDD4, AND UBIQUITINATION.
RX   PubMed=19144635; DOI=10.1074/jbc.m806877200;
RA   Chan W., Tian R., Lee Y.-F., Sit S.T., Lim L., Manser E.;
RT   "Down-regulation of active ACK1 is mediated by association with the E3
RT   ubiquitin ligase Nedd4-2.";
RL   J. Biol. Chem. 284:8185-8194(2009).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH AXL; LTK; PDGFRL AND GRB2.
RX   PubMed=19815557; DOI=10.1074/jbc.m109.072660;
RA   Pao-Chun L., Chan P.M., Chan W., Manser E.;
RT   "Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is
RT   mediated by Grb2: an analysis of ACK1 effects on Axl signaling.";
RL   J. Biol. Chem. 284:34954-34963(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-284 AND SER-724, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [26]
RP   SUBUNIT, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-284, AND DOMAIN
RP   SAM-LIKE.
RX   PubMed=20979614; DOI=10.1186/1471-2091-11-42;
RA   Prieto-Echaguee V., Gucwa A., Brown D.A., Miller W.T.;
RT   "Regulation of Ack1 localization and activity by the amino-terminal SAM
RT   domain.";
RL   BMC Biochem. 11:42-42(2010).
RN   [27]
RP   FUNCTION, SUBCELLULAR LOCATION, VARIANTS LEU-34; GLN-99; LYS-346 AND
RP   ILE-409, CHARACTERIZATION OF VARIANTS LEU-34; GLN-99; LYS-346 AND ILE-409,
RP   AND MUTAGENESIS OF LEU-120; LEU-197 AND VAL-365.
RX   PubMed=20110370; DOI=10.1074/jbc.m109.060459;
RA   Prieto-Echaguee V., Gucwa A., Craddock B.P., Brown D.A., Miller W.T.;
RT   "Cancer-associated mutations activate the nonreceptor tyrosine kinase
RT   Ack1.";
RL   J. Biol. Chem. 285:10605-10615(2010).
RN   [28]
RP   FUNCTION AS AR KINASE, AND ACTIVITY REGULATION.
RX   PubMed=20383201; DOI=10.1038/onc.2010.103;
RA   Liu Y., Karaca M., Zhang Z., Gioeli D., Earp H.S., Whang Y.E.;
RT   "Dasatinib inhibits site-specific tyrosine phosphorylation of androgen
RT   receptor by Ack1 and Src kinases.";
RL   Oncogene 29:3208-3216(2010).
RN   [29]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, INTERACTION WITH AKT1, SUBCELLULAR
RP   LOCATION, CHARACTERIZATION OF VARIANT LYS-346, PHOSPHORYLATION AT TYR-284,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=20333297; DOI=10.1371/journal.pone.0009646;
RA   Mahajan K., Coppola D., Challa S., Fang B., Chen Y.A., Zhu W., Lopez A.S.,
RA   Koomen J., Engelman R.W., Rivera C., Muraoka-Cook R.S., Cheng J.Q.,
RA   Schoenbrunn E., Sebti S.M., Earp H.S., Mahajan N.P.;
RT   "Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its
RT   activation.";
RL   PLoS ONE 5:E9646-E9646(2010).
RN   [30]
RP   PHOSPHORYLATION AT TYR-284, TISSUE SPECIFICITY, AND ACTIVITY REGULATION.
RX   PubMed=20623637; DOI=10.1002/pros.21163;
RA   Mahajan K., Challa S., Coppola D., Lawrence H., Luo Y., Gevariya H.,
RA   Zhu W., Chen Y.A., Lawrence N.J., Mahajan N.P.;
RT   "Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen
RT   receptor activity.";
RL   Prostate 70:1274-1285(2010).
RN   [31]
RP   PHOSPHORYLATION AT TYR-284, AND INTERACTION WITH SRC.
RX   PubMed=21309750; DOI=10.1042/bj20102156;
RA   Chan W., Sit S.T., Manser E.;
RT   "The Cdc42-associated kinase ACK1 is not auto-inhibited but requires Src
RT   for activation.";
RL   Biochem. J. 435:355-364(2011).
RN   [32]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT TYR-284; TYR-518; TYR-827;
RP   TYR-859 AND TYR-872.
RX   PubMed=21169560; DOI=10.1091/mbc.e10-07-0637;
RA   Shen H., Ferguson S.M., Dephoure N., Park R., Yang Y., Volpicelli-Daley L.,
RA   Gygi S., Schlessinger J., De Camilli P.;
RT   "Constitutive activated Cdc42-associated kinase (Ack) phosphorylation at
RT   arrested endocytic clathrin-coated pits of cells that lack dynamin.";
RL   Mol. Biol. Cell 22:493-502(2011).
RN   [33]
RP   REVIEW ON TUMOR GROWTH.
RX   PubMed=20432460; DOI=10.1002/jcp.22162;
RA   Mahajan K., Mahajan N.P.;
RT   "Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.";
RL   J. Cell. Physiol. 224:327-333(2010).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [35]
RP   STRUCTURE BY NMR OF 448-489.
RX   PubMed=10360579; DOI=10.1038/20732;
RA   Mott H.R., Owen D., Nietlispach D., Lowe P.N., Manser E., Lim L.,
RA   Laue E.D.;
RT   "Structure of the small G protein Cdc42 bound to the GTPase-binding domain
RT   of ACK.";
RL   Nature 399:384-388(1999).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 107-395, AND PHOSPHORYLATION AT
RP   TYR-284.
RX   PubMed=15308621; DOI=10.1074/jbc.m406703200;
RA   Lougheed J.C., Chen R.-H., Mak P., Stout T.J.;
RT   "Crystal structures of the phosphorylated and unphosphorylated kinase
RT   domains of the Cdc42-associated tyrosine kinase ACK1.";
RL   J. Biol. Chem. 279:44039-44045(2004).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 117-392 IN COMPLEX WITH INHIBITOR,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=18993068; DOI=10.1016/j.bmcl.2008.10.092;
RA   Kopecky D.J., Hao X., Chen Y., Fu J., Jiao X., Jaen J.C., Cardozo M.G.,
RA   Liu J., Wang Z., Walker N.P., Wesche H., Li S., Farrelly E., Xiao S.H.,
RA   Kayser F.;
RT   "Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-
RT   d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.";
RL   Bioorg. Med. Chem. Lett. 18:6352-6356(2008).
RN   [38]
RP   VARIANTS LEU-34; ARG-71; GLN-99; TRP-99; MET-152; LYS-346; ILE-409;
RP   SER-507; LEU-725; GLN-748 AND HIS-1038.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [39]
RP   VARIANT MET-638, INTERACTION WITH NEDD4 AND NEDD4L, AND CHARACTERIZATION OF
RP   VARIANT MET-638.
RX   PubMed=23686771; DOI=10.1002/ana.23934;
RA   Hitomi Y., Heinzen E.L., Donatello S., Dahl H.H., Damiano J.A.,
RA   McMahon J.M., Berkovic S.F., Scheffer I.E., Legros B., Rai M.,
RA   Weckhuysen S., Suls A., De Jonghe P., Pandolfo M., Goldstein D.B.,
RA   Van Bogaert P., Depondt C.;
RT   "Mutations in TNK2 in severe autosomal recessive infantile onset
RT   epilepsy.";
RL   Ann. Neurol. 74:496-501(2013).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q07912-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q07912-2; Sequence=VSP_008655, VSP_008656;
CC       Name=3;
CC         IsoId=Q07912-3; Sequence=VSP_037284, VSP_037285, VSP_037286;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS33927.1; -.
DR   RefSeq; NP_001010938.1; NM_001010938.1.
DR   ProteomicsDB; 58558; -.
DR   Ensembl; ENST00000671753.1; ENSP00000499858.1; ENSG00000061938.21.
DR   Proteomes; UP000005640; Chromosome 3.
PE   1: Evidence at protein level;
SQ   SEQUENCE   1047 AA;  115532 MW;  631443FD68560DDF CRC64;
     MGERSAYQRL AGGEEGPQRL GGGRMQPEEG TGWLLELLSE VQLQQYFLRL RDDLNVTRLS
     HFEYVKNEDL EKIGMGRPGQ RRLWEAVKRR KALCKRKSWM SKVFSGKRLE AEFPPHHSQS
     TFRKTSPAPG GPAGEGPLQS LTCLIGEKDL RLLEKLGDGS FGVVRRGEWD APSGKTVSVA
     VKCLKPDVLS QPEAMDDFIR EVNAMHSLDH RNLIRLYGVV LTPPMKMVTE LAPLGSLLDR
     LRKHQGHFLL GTLSRYAVQV AEGMGYLESK RFIHRDLAAR NLLLATRDLV KIGDFGLMRA
     LPQNDDHYVM QEHRKVPFAW CAPESLKTRT FSHASDTWMF GVTLWEMFTY GQEPWIGLNG
     SQILHKIDKE GERLPRPEDC PQDIYNVMVQ CWAHKPEDRP TFVALRDFLL EAQPTDMRAL
     QDFEEPDKLH IQMNDVITVI EGRAENYWWR GQNTRTLCVG PFPRNVVTSV AGLSAQDISQ
     PLQNSFIHTG HGDSDPRHCW GFPDRIDELY LGNPMDPPDL LSVELSTSRP PQHLGGVKRE
     PPPRPPQPAF FTQKPTYDPV SEDQDPLSSD FKRLGLRKPG LPRGLWLAKP SARVPGTKAS
     RGSGAEVTLI DFGEEPVVPA LRPCAPSLAQ LAMDACSLLD ETPPQSPTRA LPRPLHPTPV
     VDWDARPLPP PPAYDDVAQD EDDFEICSIN STLVGAGVPA GPSQGQTNYA FVPEQARPPP
     PLEDNLFLPP QGGGKPPSSA QTAEIFQALQ QECMRQLQAP AGSPAPSPSP GGDDKPQVPP
     RVPIPPRPTR PHVQLSPAPP GEEETSQWPG PASPPRVPPR EPLSPQGSRT PSPLVPPGSS
     PLPPRLSSSP GKTMPTTQSF ASDPKYATPQ VIQAPGPRAG PCILPIVRDG KKVSSTHYYL
     LPERPSYLER YQRFLREAQS PEEPTPLPVP LLLPPPSTPA PAAPTATVRP MPQAALDPKA
     NFSTNNSNPG ARPPPPRATA RLPQRGCPGD GPEAGRPADK IQMVEQLFGL GLRPRGECHK
     VLEMFDWNLE QAGCHLLGSW GPAHHKR
//
